Search results for: It's time

Home/Search: It's time
9 11, 2021

Breaking News: Additional Commentary for “It’s Time to Rethink Placebos in Advanced GIST” – LRG Science

By |2021-11-11T13:53:14-05:00November 9th, 2021|LRG Science, News, Research|

In this issue of LRG Science, we present additional commentary on our Sept. issue: "It's Time to Rethink Placebos in Advanced GIST".

22 07, 2021

‘It’s Time’ to Continue Our Message About Biomarker Testing!

By |2021-09-27T14:30:56-04:00July 22nd, 2021|Mutational Testing, News|

So far in 2021, our 'It's Time' campaign has emphasized twelve important points concerning biomarker testing and the important role it plays in a GIST patient's journey. We will keep the momentum going with patient stories, webinars, and resource materials.

1 07, 2021

It’s Time: The Life Raft Group Biomarker Testing Campaign – It’s Time to Save Lives!

By |2021-09-27T14:32:40-04:00July 1st, 2021|Mutational Testing, News|

Biomarker testing is an opportunity to improve and optimize treatment. In this post, GISTer Bill Borwegen shares his story and we share how you can help save lives.

12 04, 2021

It’s Time: The Life Raft Group Biomarker Testing Campaign – It’s Time for Action

By |2021-09-27T14:35:30-04:00April 12th, 2021|Mutational Testing, News, Video|

Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. This video shows the action steps of our It's Time campaign.

26 01, 2021

It’s Time: The Life Raft Group Biomarker Testing Campaign

By |2021-09-27T14:36:40-04:00January 26th, 2021|Mutational Testing, News|

Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is [...]

25 06, 2021

It’s Time: The Life Raft Group Biomarker Testing Campaign – Identify Subsets & Clinical Trials

By |2021-09-27T14:37:39-04:00June 25th, 2021|Mutational Testing, News|

Identifying rare subsets of GIST and starting new clinical trials is critical. Read here about one researcher's clinical trial progress.

Need a new search?

If you didn't find what you were looking for, try a new search!

Go to Top